Introduction

The rapid advancement of modern pharmaceutical research has significantly increased the demand for stable isotope-labeled compounds. Among these, METHYL-D3-AMINE HYDROCHLORIDE (CAS No. 7436-22-8) has become an essential deuterated reagent widely used in medicinal chemistry, isotope-labeling studies, and the synthesis of innovative pharmaceutical intermediates.

As a high-purity deuterated methylamine source, this compound provides an efficient way to introduce a CD₃ (trideuteromethyl) group into target molecules. Deuterium substitution has become increasingly valuable in drug discovery because it can influence metabolic stability, improve pharmacokinetic profiles, and support isotope tracing applications.

One notable application is its role as an important building block in the preparation of 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide, which can be further transformed into downstream intermediates reported in synthetic routes toward Deucravacitinib, an oral TYK2 inhibitor developed for immune-mediated inflammatory diseases.

What is METHYL-D3-AMINE HYDROCHLORIDE?

Product Name

METHYL-D3-AMINE HYDROCHLORIDE

CAS Number

7436-22-8

Molecular Formula

CD₃NH₂·HCl

Molecular Weight

Approximately 70.52 g/mol

METHYL-D3-AMINE HYDROCHLORIDE is the hydrochloride salt of deuterated methylamine, in which the three hydrogen atoms of the methyl group are replaced with deuterium atoms. This isotopic substitution creates a chemically similar reagent while providing unique advantages for pharmaceutical synthesis and analytical applications.

The hydrochloride form offers improved handling, storage stability, and transportation compared with the free amine, making it the preferred commercial form for laboratory and industrial use.

Physical and Chemical Properties

Typical specifications include:

Because deuterium exhibits nearly identical chemical behavior to hydrogen while forming slightly stronger carbon–deuterium bonds, deuterated compounds are widely employed in isotope-labeling chemistry and pharmaceutical process development.

Why Deuterated Reagents Matter in Modern Drug Development

Over the past decade, deuterium chemistry has become one of the fastest-growing areas in medicinal chemistry.

Compared with conventional hydrogen-containing compounds, deuterated molecules may offer several advantages during drug development:

• · Improved metabolic stability
• · Reduced oxidative metabolism
• · Better pharmacokinetic characteristics
• · Enhanced isotope tracing capability
• · Support for ADME studies
• · Higher analytical accuracy in LC-MS and GC-MS applications

As pharmaceutical companies continue developing next-generation small-molecule drugs, demand for high-quality deuterated reagents has expanded rapidly.

Role in Deucravacitinib Intermediate Synthesis

One of the most significant applications of METHYL-D3-AMINE HYDROCHLORIDE is its use as a deuterated methyl donor in the synthesis of pharmaceutical intermediates.

It is commonly employed in preparing:

• · 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide 

This intermediate can undergo subsequent synthetic transformations involving compounds such as:

• · 4,6-dihydroxypyridazine-3-carboxylic acid, monosodium salt 

These intermediates are associated with reported synthetic routes toward Deucravacitinib, an oral selective TYK2 inhibitor approved for the treatment of certain immune-mediated inflammatory diseases.

The incorporation of deuterium-containing reagents is also valuable during route optimization, impurity profiling, analytical method development, and isotope-labeling studies supporting pharmaceutical research.

Expanding Applications Across the Pharmaceutical Industry

Beyond Deucravacitinib-related research, METHYL-D3-AMINE HYDROCHLORIDE has broad applications in modern pharmaceutical manufacturing.

Typical application areas include:

Stable Isotope Labeling

Preparation of deuterated reference standards for analytical laboratories.

Medicinal Chemistry

Introduction of CD₃ functional groups during lead optimization and structure–activity relationship studies.

Pharmaceutical Intermediate Manufacturing

Production of deuterated heterocyclic intermediates for innovative drug development.

Analytical Chemistry

Preparation of isotope-labeled internal standards for LC-MS, GC-MS, and pharmacokinetic studies.

CRO & CDMO Projects

Custom synthesis of deuterated compounds for pharmaceutical companies and research organizations.

Market Outlook

The global market for stable isotope-labeled compounds continues to grow steadily, driven by increasing investment in innovative therapeutics, precision medicine, and analytical technologies.

Several trends are supporting demand:

Growth of Deuterated Drug Development

More pharmaceutical companies are exploring deuterium substitution strategies to optimize drug candidates and improve clinical performance.

Expansion of Targeted Therapies

Innovative kinase inhibitors, including TYK2 inhibitors, continue to generate strong demand for advanced pharmaceutical intermediates.

Rising Demand for Isotope Standards

Analytical laboratories increasingly require isotope-labeled compounds for regulatory testing, bioanalysis, and quality control.

Outsourcing of Specialty Chemical Manufacturing

Global pharmaceutical companies increasingly partner with experienced manufacturers capable of producing isotope-labeled intermediates under strict quality systems.

Why Choose SHLZ Pharma?

SHLZ Pharma is dedicated to supplying high-quality pharmaceutical intermediates, isotope-labeled compounds, and custom synthesis services for customers worldwide.

Our competitive advantages include:

Professional Deuterated Chemistry Expertise

Extensive experience in the development and manufacture of stable isotope-labeled intermediates.

High Product Purity

Each production batch undergoes comprehensive analytical testing to ensure consistent purity and isotopic integrity.

Flexible Manufacturing Capacity

From gram-scale R&D quantities to pilot and commercial production, we provide scalable manufacturing solutions tailored to customer needs.

Advanced Quality Control

Our quality management system incorporates modern analytical technologies to ensure batch consistency and compliance with pharmaceutical requirements.

Global Supply Network

With rich international export experience, SHLZ Pharma supplies pharmaceutical intermediates to customers across Europe, North America, Asia, and other global markets with efficient logistics support and responsive technical service.

Manufacturing Capability

As a trusted pharmaceutical intermediate manufacturer, SHLZ Pharma continues investing in production technology, process optimization, and quality assurance.

We provide:

• · Stable production processes
• · Competitive lead times
• · Flexible packaging options
• · Technical documentation support
• · Responsive customer service
• · Long-term supply capability
• · Custom synthesis and contract manufacturing

Whether customers require research quantities or commercial-scale supply, SHLZ Pharma is committed to delivering reliable solutions that support pharmaceutical innovation.

Conclusion

As deuterium chemistry becomes increasingly important in modern pharmaceutical research, METHYL-D3-AMINE HYDROCHLORIDE (CAS No. 7436-22-8) continues to play a vital role as a versatile isotope-labeled building block. Its application in the preparation of 4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide and other intermediates reported in synthetic routes toward Deucravacitinib highlights its value in advanced medicinal chemistry, analytical science, and pharmaceutical manufacturing.

With strong expertise in stable isotope chemistry, scalable production capabilities, and rigorous quality management, SHLZ Pharma is committed to providing reliable deuterated intermediates that help accelerate pharmaceutical development worldwide.